Down Syndrome: Screening, Diagnosis, and Health Consequences
Literature Review
DOI:
https://doi.org/10.55175/cdk.v52i2.1368Keywords:
Diagnosis, health consequences, Down syndrome, screeningAbstract
Down syndrome is congenital or genetic abnormality with extra chromosome 21 causing various clinical manifestations and health problem. Down syndrome ranked first as the most common cause of birth defect in Indonesia. Chromosomal abnormality cause Down syndrome children have a higher risk and more common health problems. Down syndrome can burden family or caregiver physically, socially, financially, and emotionally. Proper screening and diagnosis criteria need to be done to establish the diagnosis.
Downloads
References
Kliegman RM, Stanton BF, St. Geme III JW, Schor NF, Behrman RE. Nelson textbook of pediatrics. 19th Ed. Philadelphia: Elsevier Saunders; 2011 .p. 395,400-2.
Kemenkes RI. InfoDATIN: Antara fakta dan harapan sindrom Down [Internet]. 2019. Available from: https://pusdatin.kemkes.go.id/article/view/19080100002/infodatin-down-syndrom-2019.html.
Barros A, Barros AO, de Medeiros Barros GL, Santos MTBR. Burden of caregivers of children and adolescents with Down syndrome. Cienc saude colet. 2017 Nov;22(11):3625-3634. DOI: 10.1590/1413-812320172211.31102016.
Huiracocha L, Almeida C, Huiracocha K, Arteaga J, Arteaga A, Blume S. Parenting children with Down syndrome: Societal influences. J Child Health Care. 2017 Dec;21(4):488-497. DOI: 10.1177/1367493517727131.
Irwanto I. A-Z sindrom Down. Surabaya: Airlangga University Press; 2019 .p. 6-20,23-6,39-43,61-86.
Cunningham, Leveno KJ, Bloom SL, Spong CY, Dashe JS, Hoffman BL, et al. Williams obstetrics. 24th Ed. New York: McGraw-Hill; 2014 .p. 170-1,289,297-30.
Vietze PM, Arvedson JC, Bogin D, Doret W, Hanin L, Harris C, et al. Clinical practice guideline report of the recommendations: Down syndrome assessment and intervention for young children (age 0-3 years). New York State Department of Health; 2006.
Fried K. A score based on eight signs in the diagnosis of Down syndrome in the newborn. J Ment Defic Res. 1980;24(3):181-5. DOI: 10.1111/j.1365-2788.1980.tb00072.x.
Hindley D, Medakkar S. Diagnosis of Down’s syndrome in neonates. Arch Dis Child Fetal Neonatal Ed. 2002;87(3):F220-1. DOI: 10.1136/fn.87.3.f220.
Medan-Khetarpal S, Arnold G. Genetic disorders and dysmorphic conditions. Zitelli and Davis’ atlas of pediatric pysical diagnosis. 7th Ed. Philadelphia: Elsevier Saunders; 2018 .p. 1-43.
Ita MI, Weisbrod LJ, Rizvi MB. Brachycephaly. StatPearls [Internet]. 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK567709/. PMID: 33620786.
Chandra N, Cyril C, Lakshminarayana P, Nallasivam P, Ramesh A, Gopinath PM, et al. Cytogenetic evaluation of Down syndrome L a review of 1020 referral cases. Int J Hum Genet. 2010;10:87-93.
Maslen C. Babcock D, Ribinson S, Bean LJH, Dooley KJ, Willour VL, et al. CRELD1 mutation contribute to the occurrence of cardiac atrioventricular septal defects in Down syndrome. Am J Med Genet. 2006;140: 2501–5. DOI: 10.1002/ajmg.a.31494.
Verstegen RHJ, van Hout RMM, de Vries E. Epidemiology of respiratory symptoms in children with Down syndrome: A nationwide prospective web-based parent-reported study. BMC Pediatr. 2014;14(103):1–5. DOI: 10.1186/1471-2431-14-103.
Ram G, Chinen J. Infections and immunodeficiency in Down syndrome. Clin Exp Immunol. 2011;164(2):9-6. DOI: 10.1111/j.1365-2249.2011.04335.x.
Gatzoulis MA, Webb G, Daubeney P. Diagnosis and management of adult congenital heart disease. 2nd Ed. Philadelphia: Elsevier Sauders; 2011.
Amr NH. Thyroid disorders in subjects with Down syndrome: An update. Acta Biomed. 2018;89(1):132-9. DOI: 10.23750/abm.v89i1.7120.
National Down Syndrome Society. Alzheimer’s disease & Down syndrome: A practical guidebook for caregiver [Internet]. 2018. Available from: https://ndss.org/resources/alzheimers-disease-down-syndrome-practical-guidebook-caregivers.
Whooten R, Schmitt J, Schwartz A. Endocrine manifestation of Down syndrome. Curr Opin Endocrinol Diabetes Obes. 2018; 25(1):61-5. DOI: 10.1097/MED.0000000000000382.
Gillespie K, Jenkins C, Marder L, Hamilton-Shield J. Diabetes. Down’s Syndrome Association [Internet]. 2018. Available from: https://www.downssyndrome.org.uk/wp-content/uploads/2020/06/Diabetes-1st-May-KP-27th-June-SM_DSMIG.pdf.
Hasle H, Clemmensen I, Mikkelsen. Risks of leukemia and solid tumors in individuals with Down’s syndrome. Lancet 2000;355:165-9. DOI: 10.1016/S0140-6736(99)05264-2.
Wechsler J, Greene M, McDevitt M, Anastasi J, Karp JE, Le Beau MM, et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet, 2002; 32: 142-52. DOI: 10.1038/ng955.
Holmes G. Gastrointestinal disorders in Down syndrome. Gastroenterol Hepatol Bed Bench. 2014;7(1):6-8. PMID: 25436092.
Wallace RA. Clinical audit of gastrointestinal conditions occurring among adults with Down syndrome attending a specialist clinic. J Intellect Dev Disabil. 2007;32(1):45-50. DOI: 10.1080/13668250601146761.
Pavlovic M, Berenji K, Bukurov M. Screening of celiac disease in Down syndrome – Old and new dilemmas. World J Clin Cases. 2017;15(7):264-9. DOI: 10.12998/wjcc.v5.i7.264.
Lott IT. Neurological phenotypes for Down syndrome across the life span. Prog Brain Res. 2013;197:101-21. DOI: 10.1016/B978-0-444-54299-1.00006-6.
Lott IT, Head E. Dementia in Down syndrome: Unique insights for Alzheimer disease research. Nat Rev Neurol. 2019;15(3):135-47. DOI: 10.1038/s41582-018-0132-6.
Nelson LD, Siddarth P, Kepe V, Scheibel KE, Huang SC, Barrio JR, et al. Positron emission tomography of brain β-amyloid and tau levels in adults with Down syndrome. Arch Neurol. 2011;68(6):768-74. DOI: 10.1001/archneurol.2011.104.
Rice C. Prevalence of autism spectrum disorders—Autism and developmental disabilities monitoring network, 14 sites, United States, 2002. Centers for Disease Control and Prevention [Internet]. 2022. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/ss5601a2.htm.
Mundakel GT. Down syndrome. Medscape [Internet]. 2020. Available from: https://emedicine.medscape.com/article/943216-overview.
Patkee PA, Baburamani AA, Kyriakopoulou V, Davidson A, Avini E, Dimitrova R, et al. Early alterations in cortical and cerebellar regional brain growth in Down syndrome: An in vivo fetal and neonatal MRI assessment. NeuroImage Clin. 2020;25:102139. DOI: 10.1016/j.nicl.2019.102139.
Del Hoyo Soriano L, Rosser T, Hamilton D, Wood T, Abbeduto L, Sherman S. Gestational age is related to symptoms of attention deficit/hyperactivity disorder in late-preterm to full-term children and adolescents with Down syndrome. Scient Rep.2020;10:20345. DOI: 10.1038/s41598-020-77392-5.
Moreau M, Benhaddou S, Dard R, Tolu S, Hamze R, Vialard F, et al. Metabolic diseases and Down syndrome: How are they linked together? Biomedicines 2021;9:221. DOI: 10.3390/biomedicines9020221.
Illouz T, Biragyn A, Lulita MF, Flores-Aguilar L, Dierssen M, Toma ID, et al. Immune dysregulation and the increased risk of complications and mortality following respiratory tract infections in adults with Down syndrome. Front Immunol. 2021;12:621440. DOI: 10.3389/fimmu.2021.621440.
Shott SR. Down syndrome: Common otolaryngologic manifestations. Am J Med Genet C Semin Med Genet. 2006;142C(3):131-40. DOI: 10.1002/ajmg.c.30095.
National Down Syndrom Society. Ear, nose & throat issues & Down syndrome [Internet]. 2021. Available from: https://ndss.org/resources/earnose-throat-ent-down-syndrome.
Izquierdo NJ. Ophthalmologic manifestation of Down syndrome. Medscape [Internet]. 2018. Available from: https://emedicine.medscape.com/article/1200824-overview.
Kunesh MG, Motley WW, Utz VM. Down syndrome (trisomy 21). American Academy of Opthalmology [Internet]. 2017 Nov 20. Available from: https://www.aao.org/education/disease-review/down-syndrome-trisomy-21.
Janniger CK. Dermatologic manifestations of Down syndrome. Medscape [Internet]. 2021. Available from: https://emedicine.medscape.com/article/1113071-overview.
Gregersen PA, Stausbøl-Grøn B, Ramsing M, Sommerlund M. Elastosis perforans serpiginosa in a patient with Down syndrome treated with imiquimod 5% cream. Dermatol Rep. 2010;2(2):15. DOI: 10.4081/dr.2010.e15.
Foley C, Kileen OG. Musculoskeletal anomalies in children with Down syndrome: An observational study. Arch Dis Child. 2019;104(5):482-7. DOI: 10.1136/archdischild-2018-315751.
Myerelid A. Down syndrome: Growth and endocrine impacts [Dissertation]. Acta Universitatis Upsaliensis: Faculty of Medicine; 2009 .p. 465-7.
van Gameren-Oosterom HB, Fekkes M, Buitendijk SE, Mohangoo AD, Bruil J, Van Wouwe JP. Development, problem behavior, and quality of life in a population based sample of eight-year-old children with Down syndrome. PLoS One 2011;6(7):e21879. DOI: 10.1371/journal.pone.0021879.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Evita Zevanya
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
